Top Banner
January 14-15, 2011 SCA Conference 1 Irregular Heart Beats/Palpitations Anjan S Batra, M.D Director of Electrophysiology Associate Professor of Pediatrics University of California-Irvine CASE 1 A 12 year old presents with a fast heart rate. He is otherwise asymptomatic. A wide complex h th i td t t f 260 b Hi bl d rhythm is noted at a rate of 260 bpm. His blood pressure is 92/50. The next best course of action would be:
14

Irregular Heart Beats/Palpitations Batra 2 20 pm.pdf · stress testing will not produce ventricular ectopy.1 • During exercise stress testing, bidirectional VT with a beat-to-beat

Aug 22, 2020

Download

Documents

dariahiddleston
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Irregular Heart Beats/Palpitations Batra 2 20 pm.pdf · stress testing will not produce ventricular ectopy.1 • During exercise stress testing, bidirectional VT with a beat-to-beat

January 14-15, 2011 SCA Conference 1

Irregular Heart Beats/Palpitations

Anjan S Batra, M.DDirector of ElectrophysiologyAssociate Professor of PediatricsUniversity of California-Irvine

CASE 1• A 12 year old presents with a fast heart rate. He

is otherwise asymptomatic. A wide complex h th i t d t t f 260 b Hi bl drhythm is noted at a rate of 260 bpm. His blood

pressure is 92/50. The next best course of action would be:

Page 2: Irregular Heart Beats/Palpitations Batra 2 20 pm.pdf · stress testing will not produce ventricular ectopy.1 • During exercise stress testing, bidirectional VT with a beat-to-beat

January 14-15, 2011 SCA Conference 2

A. AdenosineB. SotalolC. AmiodaroneD. VerapamilE. DC cardioversion

SVT

• In a hemodynamically stable patient, t i l t h di itha supraventricular tachycardia with

aberrant conduction is the most likely rhythm.

• The best treatment for this patient would be administration of adenosinewould be administration of adenosine to terminate the tachycardia.

Page 3: Irregular Heart Beats/Palpitations Batra 2 20 pm.pdf · stress testing will not produce ventricular ectopy.1 • During exercise stress testing, bidirectional VT with a beat-to-beat

January 14-15, 2011 SCA Conference 3

CASE 2An 8 year old presents with a fast heart rate and difficulty breathing. Blood pressure is stable. An ECG is obtained and shown below. There is no change in the heart rate with adenosine. Your next gcourse of action would be:

A. DC cardioversionB. Sedation and atrial overdrive pacingC. DigoxinD. Beta blockersE. Verapamil

Page 4: Irregular Heart Beats/Palpitations Batra 2 20 pm.pdf · stress testing will not produce ventricular ectopy.1 • During exercise stress testing, bidirectional VT with a beat-to-beat

January 14-15, 2011 SCA Conference 4

Fascicular Ventricular Tachycardia

• Originating from the left ventricle. • Adenosine is usually not effective in

terminating the tachycardia. • Calcium channel blockers are very

effective and hence this tachycardia is also referred to as verapamil sensitivealso referred to as verapamil sensitive ventricular tachycardia.

• This is usually amenable to ablation.

CASE 3:A 12 year old boy is undergoing a stress test for frequent ectopy at baseline. The echocardiogram at rest was normal. You notice the following rhythm at stage 5 of the standard Bruce protocol. The diagnosis is most consistent with:

Page 5: Irregular Heart Beats/Palpitations Batra 2 20 pm.pdf · stress testing will not produce ventricular ectopy.1 • During exercise stress testing, bidirectional VT with a beat-to-beat

January 14-15, 2011 SCA Conference 5

A Brugada SyndromeA. Brugada SyndromeB. CPVTC. Long QT type 3D. MyocarditisE. Artifact

Catecholaminergic ventricular

tachycardia (CPVT).• Polymorphic ventricular tachycardia

ith iwith exercise• Brugada syndrome and long QT

type3– polymorphic ventricular tachycardia

generally at rest or during sleep. g y g p• Myocarditis: decrease in cardiac

function.

Page 6: Irregular Heart Beats/Palpitations Batra 2 20 pm.pdf · stress testing will not produce ventricular ectopy.1 • During exercise stress testing, bidirectional VT with a beat-to-beat

January 14-15, 2011 SCA Conference 6

CPVT• CPVT cannot be diagnosed on the basis of a resting ECG.1,2

• Exercise stress testing is an important part of a CPVT workup.

– However, in as many as 20% of CPVT patients, formal exercise stress testing will not produce ventricular ectopy.1

• During exercise stress testing, bidirectional VT with a beat-to-beat 180-degree rotation of the QRS complex is often observed.1

References: 1. Mohamed U, Napolitano C, Priori SG. Molecular and electrophysiological bases of catecholaminergic polymorphic ventricular tachycardia. J Cardiovasc Electrophysiol. 2007;18:791-797. 2. Kontula K, Laitinen PJ, Lehtonen A, Toivonen L, Viitasalo M, Swan H. Catecholaminergic polymorphic ventricular tachycardia: recent mechanistic insights. Cardiovasc Res. 2005;67:379-387.

Mutations in the Cardiac Ryanodine Receptor Gene (RYR2) Are the Major Cause of CPVT

• 60-65% of CPVT is caused by mutations of th di di

RYR2

the cardiac ryanodine receptor gene, which encodes a sarcoplasmic calcium ion channel.1,2

References: 1. Mohamed U, Napolitano C, Priori SG. Molecular and electrophysiological bases of catecholaminergic polymorphic ventricular tachycardia. J Cardiovasc Electrophysiol. 2007;18(7):791-797. 2. Hayashi M, Denjoy I, Extramiana F, et al. Incidence and Risk Factors of Arrhythmic Events in Catecholaminergic Polymorphic Ventricular Tachycardia. Circulation. 2009;119:2426-34.

12

Page 7: Irregular Heart Beats/Palpitations Batra 2 20 pm.pdf · stress testing will not produce ventricular ectopy.1 • During exercise stress testing, bidirectional VT with a beat-to-beat

January 14-15, 2011 SCA Conference 7

It Is Important to Differentiate Between CPVT and LQTS

• CPVT is an LQTS mimicker.1

• As many as 30% of CPVT patients have been misdiagnosed as having “Long QT with normal QTc.”2,3

• Differentiating CPVT from LQTS is important for:- Developing a comprehensive treatment plan- Family-specific testing

References: 1. Choi G, Kopplin LJ, Tester DJ, et al. Spectrum and frequency of cardiac channel defects in swimming-triggered arrhythmia syndromes. Circulation. 2004;110:2119-2124. 2. Priori SG, Napolitano C, Memmi M, et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation. 2002;106:69-74. 3. Napolitano C, Priori SG. Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm. 2007;4:675-678.

13

Beta-blockers Do Not Provide Reliable ProtectionAgainst Cardiac Arrhythmias Related to CPVT

• “However in light of incomplete protection• However, in light of incomplete protection afforded by beta-blockers in CPVT, its distinction from long-QT is clinically relevant.”1

• Nearly 50% of CPVT patients taking a beta-blocker continue experiencing cardiac arrhythmias and may require an ICD 1arrhythmias and may require an ICD.1

Reference: 1. Priori SG, Napolitano C, Memmi M, et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation. 2002;106:69-74.

14

Page 8: Irregular Heart Beats/Palpitations Batra 2 20 pm.pdf · stress testing will not produce ventricular ectopy.1 • During exercise stress testing, bidirectional VT with a beat-to-beat

January 14-15, 2011 SCA Conference 8

Brugada Syndrome• The ECG of patients with BrS is characterized by

– Coved- or saddleback-shaped ST-segment elevation in leads V1 through V31

– complete or incomplete right bundle-branch blockcomplete or incomplete right bundle branch block– T-wave inversion1

• These ECG abnormalities may not be evident until unmasked by infusion of a sodium channel blocker (flecainide or procainamide).1

References: 1. Brugada R, Brugada P, Brugada J, Hong K. Brugada syndrome. Gene Reviews Web site. Available at: http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=brugada. Accessed May 25, 2009. 2. Rossenbacker T and Priori SG. The Brugada Syndrome. Curr Opin Cardiol. 2007;22:163-70.

BrS Typically Presents in Men 30-40 Years of Age

• The most common presentation of BrS is a man 30-40 years of age with malignant arrhythmias and a history of syncope 1,2 age with malignant arrhythmias and a history of syncope.

– Men are 8-10 times more likely than women to have the BrS phenotype.1,2

– There is no difference between men and women in the prevalence of gene mutations associated with BrS.1,2

• Men with an abnormal ECG and inducible ventricular arrhythmias have a poor prognosis.1,2

• If untreated, men with BrS have a 45% chance of having a cardiac event over the course of their life.1

References: 1. Brugada R, Brugada P, Brugada J, Hong K. Brugada syndrome. Gene Reviews Web site. Available at: http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=brugada. Accessed May 25, 2009. 2. Rossenbacker T and Priori SG. The Brugada Syndrome. Curr Opin Cardiol. 2007;22:163-70.

16

Page 9: Irregular Heart Beats/Palpitations Batra 2 20 pm.pdf · stress testing will not produce ventricular ectopy.1 • During exercise stress testing, bidirectional VT with a beat-to-beat

January 14-15, 2011 SCA Conference 9

CASE 4• A 14 year old patient with a history of WPW

and SVT presents with this ECG. He is alert and hemodynamically stable. The MOST appropriate therapy is:

A. AdenosineB. LidocaineC.ObservationD.DC cardioversionE. IV calcium channel blocker

Page 10: Irregular Heart Beats/Palpitations Batra 2 20 pm.pdf · stress testing will not produce ventricular ectopy.1 • During exercise stress testing, bidirectional VT with a beat-to-beat

January 14-15, 2011 SCA Conference 10

WPW

• Atrial fibrillation with rapid conduction th th lt iover the accessory pathway results in

a rapid ventricular response.• At risk for ventricular fibrillation and

compromised circulation.• Adenosine can also induce atrial• Adenosine can also induce atrial

fibrillation.• DC Cardioversion should be readily

available.

CASE 5• A 12 year old boy comes to you with palpitations

with exercise. He also complains of occasional chest pain with exercise. You obtain an ECG which is shown below. The next most obvious recommendation would be to:

Page 11: Irregular Heart Beats/Palpitations Batra 2 20 pm.pdf · stress testing will not produce ventricular ectopy.1 • During exercise stress testing, bidirectional VT with a beat-to-beat

January 14-15, 2011 SCA Conference 11

• a. Perform an exercise stress test. • b. Clear him for sports without any restrictions. • c. Perform an echocardiogram. • d. Perform a CXR. • e. Perform a 30 day event monitor.

Left ventricular hypertrophy with a strain pattern.

• At risk for ventricular tachycardia and dd di d th ith isudden cardiac death with exercise

• Additional risk factors – family history of premature sudden death– extreme LV hypertrophy (> 30 mm)– NS ventricular tachycardia on Holter– NS ventricular tachycardia on Holter– unexplained (not neurally mediated)

syncope

Page 12: Irregular Heart Beats/Palpitations Batra 2 20 pm.pdf · stress testing will not produce ventricular ectopy.1 • During exercise stress testing, bidirectional VT with a beat-to-beat

January 14-15, 2011 SCA Conference 12

The Clinical Presentation of HCM• HCM is a progressive disease associated with varying degrees of LVH with

no apparent cause.1

- Thickening typically develops during late childhood and throughout adolescence.1

23 Reference: 1. Keren A, Syrris P, McKenna WJ. Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression. Nature. 2008;5:158-168.

Obstructive and Non-obstructive HCM

LVH is usually maximal in the interventricular septum, but other localized variants have been documented.1

24Reference: 1. Keren A, Syrris P, McKenna WJ. Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression. Nature. 2008;5:158-168.

Page 13: Irregular Heart Beats/Palpitations Batra 2 20 pm.pdf · stress testing will not produce ventricular ectopy.1 • During exercise stress testing, bidirectional VT with a beat-to-beat

January 14-15, 2011 SCA Conference 13

The Clinical Diagnosis of HCM Relies Primarily on Echocardiogram

Echocardiogram can help determine:

• Location and extent of hypertrophy

• Systolic and diastolic function

• The presence and degree of systolic anterior motion

• The severity of subaortic and/or midventricular obstruction

25

obstruction

• Direction and degree of mitral regurgitation

• The presence or absence of additional mitral valve abnormalities

• Left atrial size

QUESTIONS

Page 14: Irregular Heart Beats/Palpitations Batra 2 20 pm.pdf · stress testing will not produce ventricular ectopy.1 • During exercise stress testing, bidirectional VT with a beat-to-beat

January 14-15, 2011 SCA Conference 14

CASE 6A 21 year old patient with classic Fontan presents with palpitations and fast heart rates for 3 days. ECG shows an unvarying heart rate of 140 bpm. He usually has a heart rate between 60 to 90 bpm. His blood pressure is stable. The following ECG is obtained. The next most appropriate intervention would be: pp p

• a. Echocardiogram• b. Digoxin• c. Adenosine• d. Sotalol• e. Amiodarone